Arbele Limited
PrivateLast Round
Seed
Apr 7, 2021
Total Funding Raised
$428,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arbele Limited operates in Healthcare & Life Sciences and is based in Hong Kong. Its latest recorded funding round was a Seed round in April 2021.
Arbele Limited is a biotechnology company that develops multi-specific antibody therapeutics, antibody-drug conjugates (ADCs), and cell therapies for treating gastrointestinal cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arbele Limited Comparables
Compare Arbele Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biosion, Inc. | 84% | |
| BioRay Pharmaceutical Co., Ltd. | 82% | |
| Chimeric Therapeutics Limited | 80% |
For institutional investors. Book with your work email.
Arbele Limited Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arbele Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asian Fund for Cancer Research | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 168% MoM, from 407 to 1.1K.
- Feb 12, 2026
Grew 25% QoQ, from 16 to 20 employees.
For institutional investors. Book with your work email.
Arbele Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arbele Limited's valuation, stock price, and market status.
Is Arbele Limited a public or private company?
Arbele Limited is a private company.
What is the current stock price of Arbele Limited?
Arbele Limited is a private company, so its shares have no public market price. Caplight tracks Arbele Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arbele Limited worth (valuation)?
Valuation information for Arbele Limited is not publicly available.
Can I buy Arbele Limited stock?
Arbele Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arbele Limited's last funding round?
Arbele Limited's most recent funding round was Seed on April 7, 2021.
Who are the main investors in Arbele Limited?
Key investors in Arbele Limited include Asian Fund for Cancer Research.
Will Arbele Limited IPO soon?
No public IPO plans have been announced for Arbele Limited.
How can I track Arbele Limited secondary market activity?
Caplight tracks bids, offers, and trades in Arbele Limited's shares on secondary markets.